Takeda Pharmaceutical
312 hedge funds and large institutions have $1.24B invested in Takeda Pharmaceutical in 2023 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 112 increasing their positions, 92 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.23% less ownership
Funds ownership: 5.31% → 5.08% (-0.23%)
6% less capital invested
Capital invested by funds: $1.32B → $1.24B (-$76.5M)
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
Holders
312
Holding in Top 10
4
Calls
$44.1M
Puts
$4.14M
Top Buyers
| 1 | +$21M | |
| 2 | +$10.5M | |
| 3 | +$7.05M | |
| 4 |
LP
LMR Partners
London,
United Kingdom
|
+$5.6M |
| 5 |
SGI
Summit Global Investments
Bountiful,
Utah
|
+$3.82M |
Top Sellers
| 1 | -$42.3M | |
| 2 | -$33.4M | |
| 3 | -$10.3M | |
| 4 |
Jane Street
New York
|
-$9.08M |
| 5 |
OMC
Old Mission Capital
Chicago,
Illinois
|
-$8.29M |